Skip to main content
SpringerLink
Log in

Huntington Disease: Genetics, Prevention, and Therapy Approaches

  • Conference paper
  • First Online:
GeNeDis 2016

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 987))

Abstract

Huntington’s chorea or Huntington disease (HD) is a late-onset autosomal dominant neurodegenerative disorder caused by a trinucleotide repeat expansion. The multidisciplinary study of HD has been the focus of an international collaborating effort of basic and applied research for several decades. HD was the first human genetic disease mapped using linkage analysis of DNA polymorphisms and became a paradigm for scores of genes mapped in the same manner. Presymptomatic and prenatal testing have been available for HD families in the last 30 years, following genetic counseling and careful bioethical guidelines. Nevertheless, with the cure for the disease still elusive the uptake of predictive testing by at risk individuals is low. Current treatment of HD is mostly symptomatic, but ongoing observational studies, clinical trials and development of new gene silencing technologies have provided hopeful results.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Huntington, G. 1872. On Chorea. Medical Surgical Report 26: 317–321.

    Google Scholar 

  2. Durbach, N., and M.R. Hayden. 1993. George Huntington: The Man Behind the Eponym. Journal of Medical Genetics 30 (5): 406–409.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Myrianthopoulos, N.C. 1966. Huntington’s Chorea. Journal of Medical Genetics 3 (4): 298–314.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Wexler, A. 1996. Mapping Fate: A Memoir of Family, Risk, and Genetic Research. California: University of California Press.

    Google Scholar 

  5. Gusella, J.F., N.S. Wexler, P.M. Conneally, S.L. Naylor, M.A. Anderson, R.E. Tanzi, P.C. Watkins, K. Ottina, M.R. Wallace, A.Y. Sakaguchi, et al. 1983. A Polymorphic DNA Marker Genetically Linked to Huntington’s Disease. Nature 306: 234–238.

    Article  CAS  PubMed  Google Scholar 

  6. MacDonald, M.E., S.V. Cheng, M. Zimmer, J.L. Hains, A.M. Poustka, B.A. Allitto, B. Smith, et al. 1989. Clustering of Multiallele DNA Markers Near the Huntington’s Disease Gene. The Journal of Clinical Investigation 84: 1013–1016.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Snell, R.G., L.M. Thompson, D.A. Tagle, T.L. Holloway, G. Barnes, H.G. Harley, L.A. Sandkuijl, et al. 1992. A Recombination Event That Redefines the Huntington Disease Region. American Journal of Human Genetics 51: 357–362.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. The World Federation of Neurology Research Group on Huntington’s Disease. 1993. Presymptomatic Testing for Huntington’s Disease: A World Wide Survey. Journal of Medical Genetics 30: 1020–1022.

    Article  Google Scholar 

  9. The Huntington’s Disease Collaborative Research Group. 1993. A Novel Gene (HTT) Containing a Trinucleotide Repeat That Is Expanded and Unstable on Huntington’s Disease Chromosomes. Cell 72: 971–983.

    Article  Google Scholar 

  10. Ross, C.A., E.H. Aylward, E.J. Wild, D.R. Langbehn, J.D. Long, J.H. Warner, R.I. Scahill, B.R. Leavitt, J.C. Stout, J.S. Paulsen, R. Reilmann, P.G. Unschuld, A. Wexler, R.L. Margolis, and S.J. Tabrizi. 2014. Huntington Disease: Natural History, Biomarkers and Prospects for Therapeutics. Nature Review Neurology 10: 204–216.

    Article  CAS  Google Scholar 

  11. Harper, P.S., ed. 1996. Huntington's Disease. 2nd ed. London, UK: Saunders Publications.

    Google Scholar 

  12. Reilmann, R., B.R. Leavitt, and C.A. Ross. 2014. Diagnostic Criteria for Huntington’s Disease Based on Natural History. Movement Disorders 29: 1335–1341.

    Article  PubMed  Google Scholar 

  13. Novak, M.J., and S.J. Tabrizi. 2010. Huntington’s Disease. British Medical Journal 340: c3109.

    Article  PubMed  Google Scholar 

  14. Nance, M., J.S. Paulsen, A. Rosenblatt, and V. Wheelock. 2011. A Physician’s Guide to the Management of Huntington’s Disease. 3rd ed. USA: Huntington’s Disease Society of America.

    Google Scholar 

  15. Quarrell, O.W., A.L. Meredith, A. Tyler, S. Youngman, M. Upadhyaya, and P.S. Harper. 1987. Exclusion Testing for Huntington’s Disease in Pregnancy with a Closely Linked DNA Marker. Lancet 1 (8545): 1281–1283.

    Article  CAS  PubMed  Google Scholar 

  16. Hayden, M.R., J. Hewitt, J.J. Kastelein, S. Langlois, R.D. Wilson, S. Fox, C. Hilbert, and M. Bloch. 1987. First-Trimester Prenatal Diagnosis for Huntington’s Disease with DNA Probes. Lancet 1 (8545): 1284–1285.

    Article  CAS  PubMed  Google Scholar 

  17. Farrer, L.A., R.H. Myers, L.A. Cupples, and P.M. Conneally. 1988. Considerations in Using Linkage Analysis as a Presymptomatic Test for Huntington’s Disease. Journal of Medical Genetics 25: 577–588.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Harper, P.S., M.J. Morris, and A. Tyler. 1990. Genetic Testing for Huntington’s Disease. British Medical Journal 300: 1089–1090.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Yapijakis C. Molecular Genetic Study of Huntington’s Chorea and Myotonic Dystrophy in Greek Families. Doctorate Dissertation Thesis, Department of Biology, University of Athens, 1993.

    Google Scholar 

  20. Yapijakis, C., F. Laccone, and S.A. Sorensen. 2002. Predictive and Prenatal Testing for Huntington’s Disease in Greece, Germany, Austria, Switzerland and Denmark. In Prenatal Testing for Late Onset Neurogenetic Diseases, ed. G. Evers-Kiebooms, M. Zoeteweij, and P.S. Harper. Oxford, UK: BIOS Scientific Publishers.

    Google Scholar 

  21. Yapijakis, C., D. Vassilopoulos, M. Tzagournisakis, T. Maris, C. Fesdjian, C. Papageorgiou, and A. Plaitakis. 1995. Linkage Disequilibrium Between the Expanded (CAG)n Repeat and an Allele of the Adjacent (CCG)n Repeat in Huntington’s Disease Patients of Greek Origin. European Journal of Human Genetics 3: 228–234.

    CAS  PubMed  Google Scholar 

  22. Fiszer, A., and W.J. Krzyzosiak. 2013. RNA Toxicity in Polyglutamine Disorders: Concepts, Models, and Progress of Research. Journal of Molecular Medicine 91: 683–691.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Εvers-Kiebooms, G., K. Nys, P. Harper, M. Zoeteweij, A. Durr, G. Jacopini, C. Yapijakis, and S. Simpson. 2002. Predictive DNA Testing for Huntington’s Disease and Reproductive Decision Making: A European Collaborative Study. European Journal of Human Genetics 10: 167–176.

    Article  Google Scholar 

  24. Simpson, S., M. Zoeteweij, K. Nys, P. Harper, A. Durr, G. Jacopini, C. Yapijakis, and G. Evers-Kiebooms. 2002. Prenatal Testing for Huntington’s Disease: A European Collaborative Study. European Journal of Human Genetics 10: 689–693.

    Article  PubMed  Google Scholar 

  25. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington’s Chorea. 1994. Guidelines for the Molecular Genetics Predictive test in Huntington’s Disease. Neurology 44: 1533–1536.

    Article  Google Scholar 

  26. MacLeod, R., A. Tibben, M. Frontali, G. Evers-Kiebooms, A. Jones, A. Martinez-Descales, and R.A. Roos. 2013. Editorial Committee and Working Group ‘Genetic Testing Counselling’ of the European Huntington Disease Network. Recommendations for the Predictive Genetic Test in Huntington’s Disease. Clinical Genetics 83: 221–231.

    Article  CAS  PubMed  Google Scholar 

  27. Evers-Kiebooms, G., and M. Zoeteweij. 2002. In Prenatal Testing for Late Onset Neurogenetic Diseases, ed. P.S. Harper. Oxford, UK: BIOS.

    Chapter  Google Scholar 

  28. Walker, F.O. 2007. Huntington’s Disease. Lancet 369: 218–228.

    Article  CAS  PubMed  Google Scholar 

  29. Bouchghoul, H., S.F. Clément, D. Vauthier, C. Cazeneuve, S. Noel, M. Dommergues, D. Héron, J. Nizard, M. Gargiulo, and A. Durr. 2016. Prenatal Testing in Huntington Disease: After the Test, Choices Recommence. European Journal of Human Genetics 24: 1535–1540.

    Article  CAS  PubMed  Google Scholar 

  30. Vinther-Jensen, T., I.U. Larsen, L.E. Hjermind, E. Budtz-Jørgensen, T.T. Nielsen, A. Nørremølle, J.E. Nielsen, and A. Vogel. 2014. A Clinical Classification Acknowledging Neuropsychiatric and Cognitive Impairment in Huntington’s Disease. Orphanet Journal of Rare Diseases 9: 114.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Dorsey, R., K. Biglan, S. Eberly, P. Auinger, A. Brocht, C.C. Umeh, D. Oakes, K. Clarence-Smith, F. Marshall, I. Shoulson, and S. Frank. 2011. Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study. PLoS Curr 3: RRN1283.

    Article  PubMed  PubMed Central  Google Scholar 

  32. www.huntington-study-group.org/ClinicalResearch/.

  33. Tabrizi, S.J., R.I. Scahill, G. Owen, A. Durr, B.R. Leavitt, R.A. Roos, B. Borowsky, B. Landwehrmeyer, C. Frost, H. Johnson, D. Craufurd, R. Reilmann, J.C. Stout, and D.R. Langbehn. 2013. TRACK-HD Investigators. Predictors of Phenotypic Progression and Disease Onset in Premanifest and Early-Stage Huntington’s Disease in the TRACK-HD Study: Analysis of 36-Month Observational Data. Lancet Neurology 12: 637–649.

    Article  PubMed  Google Scholar 

  34. Stout, J.C., S. Queller, K.N. Baker, S. Cowlishaw, C. Sampaio, C. Fitzer-Attas, B. Borowsky, and HD-CAB Investigators. 2014. HD-CAB: A Cognitive Assessment Battery for Clinical Trials in Huntington’s Disease 1,2,3. Movement Disorders 29: 1281–1288.

    Article  PubMed  Google Scholar 

  35. Niccolini, F., and M. Politis. 2014. Neuroimaging in Huntington’s Disease. World Journal of Radiology 6: 301–312.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Cheng, K. 2011. Recent Progress in High-Resolution Functional MRI. Current Opinion in Neurology 24: 401–408.

    Article  PubMed  Google Scholar 

  37. Sritharan, A., G.F. Egan, L. Johnston, M. Horne, J.L. Bradshaw, I. Bohanna, H. Asadi, R. Cunnington, A.J. Churchyard, P. Chua, M. Farrow, and N. Georgiou-Karistianis. 2010. A Longitudinal Diffusion Tensor Imaging Study in Symptomatic Huntington’s Disease. Journal of Neurology Neurosurgery and Psychiatry 81: 257–262.

    Article  Google Scholar 

  38. Mandelli, M.L., M. Savoiardo, L. Minati, C. Mariotti, D. Aquino, A. Erbetta, S. Genitrini, S. Di Donato, M.G. Bruzzone, and M. Grisoli. 2010. Decreased Diffusivity in the Caudate Nucleus of Presymptomatic Huntington Disease Gene Carriers: Which Explanation? American Journal of Neuroradiology 31: 706–710.

    Article  CAS  PubMed  Google Scholar 

  39. Plerou A, Bobori C, Vlamos P. Molecular Basis of Huntington’s Disease and Brain Imaging Evidence. The 15th IEEE International Symposium on Signal Processing and Information Technology, Abu Dhabi, December 2015. doi:10.1109/ISSPIT.2015.7394365.

    Google Scholar 

  40. Sah, D.W., and N. Aronin. 2011. Oligonucleotide Therapeutic Approaches for Huntington Disease. The Journal of Clinical Investigation 121: 500–507.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The author is pleased to express his gratitude to Professor Emeritus of Internal Medicine Dimitris Loukopoulos for instructive mentoring during the author’s PhD thesis, and late Professor of Neurology Constantinos Papageorgiou for the opportunity he gave to the author to establish the Laboratory of Molecular Neurogenetics at Eginition Hospital immediately after the completion of his PhD thesis research. Special thanks are offered to the HD patients and their families, as well as to members of the International HD Collaborative Research Group, and especially Professor Emeritus Peter Harper and Professor Gerry Evers-Kiebooms for fruitful collaboration.

Author information

Authors and Affiliations

  1. Department of Oral and Maxillofacial Surgery, School of Medicine, University of Athens, Attikon Hospital, Athens, Greece

    Christos Yapijakis

  2. “Cephalogenetics” Genetic Center, Athens, Greece

    Christos Yapijakis

  3. Department of Neurology, School of Medicine, University of Athens, Eginition Hospital, Athens, Greece

    Christos Yapijakis

Authors
  1. Christos Yapijakis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christos Yapijakis .

Editor information

Editors and Affiliations

  1. Department of Informatics, Bioinformatics and Human Electrophysiology Laboratory, Ionian University, Corfu, Greece

    Panayiotis Vlamos

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this paper

Cite this paper

Yapijakis, C. (2017). Huntington Disease: Genetics, Prevention, and Therapy Approaches. In: Vlamos, P. (eds) GeNeDis 2016. Advances in Experimental Medicine and Biology, vol 987. Springer, Cham. https://doi.org/10.1007/978-3-319-57379-3_6

Download citation

Publish with us

Policies and ethics

Search

Navigation